ARTICLE | Clinical News
Xeloda capecitabine regulatory update
October 25, 2010 7:00 AM UTC
Roche disclosed in its earnings that it submitted a Japanese marketing application last quarter to expand the label of Xeloda capecitabine to include treatment of advanced or refractory gastric cancer...